UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 15, 2024
Accession Number:
0001140361-24-007880
Submission Type:
POS AM
CIK:
0001745020
Company Name:
Theseus Pharmaceuticals, Inc.
File Number:
333-268125